As part of the SIU ‘From Idea to Start-up’ event series, SIULondon hosted speakers to share their expertise on the topic of exploring the therapeutic potential of genetic engineering. Read on to learn about innovative companies Shift Bioscience, Touchlight Genetics and more…
We recently spoke to Richard Ashcroft, Professor of Bioethics and Head Deputy of the Department of Law at Queen Mary University to learn more about the importance of addressing ethical questions in the emerging field of genetic engineering. Read on for more.
In this opinion piece, PhD student Layal Liverpool argues why scientists have the responibility to engage with the public. How is social media influencing genuine science communication and can policy makers be better informed on STEM fields? Read here for more..
Fixing genes, introducing them to a patient and making the patient's body accept the newly introduced genes are challenges we were not able to overcome until recently. Now, with the advance of genome editing techniques and the use of stem cells, we are closer than ever. Here we bring you the insight on how it would work to combine these two biological tools to fight disease.
The advent of CRISPR has meant that gene editing in humans is becoming a reality. But what are the realistic medical outcomes and potential hiccups of this new technology?